LGT Financial Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1
Closed -$391 466
2025
Q2
$391 Buy
+1
New +$402 ﹤0.01% 451
2023
Q4
Sell
-8
Closed -$3.48K 884
2023
Q3
$3.48K Sell
8
-1,935
-100% -$878K ﹤0.01% 697
2023
Q2
$863K Buy
1,943
+1,076
+124% +$496K 0.92% 35
2023
Q1
$399K Buy
+867
New +$413K 0.74% 29

Other funds holding ELV

LGT Financial Advisors's ELV Position: Q3 2025 in Review

LGT Financial Advisors sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 1 share — an estimated $391 sold.

LGT Financial Advisors first reported a position in ELV in Q1 2023 and held it in 4 quarters. The position peaked at $863K in Q2 2023. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • LGT Financial Advisors reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • LGT Financial Advisors sold 1 Elevance Health share in Q3 2025, an estimated $391.
  • LGT Financial Advisors first reported a position in Elevance Health in Q1 2023 and held it in 4 quarters.
  • LGT Financial Advisors's Elevance Health position peaked at $863K in Q2 2023.
  • 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on LGT Financial Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.